The Shady History of Big Sugar
Charlottesville, Va. —
The Shady History of Big Sugar
Charlottesville, Va. — On Monday, an article in JAMA Internal Medicine reported that in the 1960s, the sugar industry paid Harvard scientists to publish a study blaming fat and cholesterol for coronary heart disease while largely exculpating sugar.
This study, published in the prestigious New England Journal of Medicine in 1967, helped set the agenda for decades of public health policy designed to steer Americans into low-fat foods, which increased carbohydrate consumption and exacerbated our obesity epidemic.
This revelation rightly reminds us to view industry-funded nutrition science with skepticism and to continue to demand transparency in scientific research. But ending Big Sugar’s hold on the American diet will require a broader understanding of the various ways in which the industry, for 150 years, has shaped government policy in order to fuel our sugar addiction.
Today’s sugar industry is a product of the 19th century, when the key federal sugar policy was not a dietary guideline but a tariff on sugar imports. In the decades after the Civil War, Americans’ per capita consumption of sugar more than doubled, from 32 pounds in 1870 to 80 pounds in 1910. As a result, the government got hooked on sugar, too: By 1880, sugar accounted for a sixth of the federal budget.
To protect domestic refiners, then the largest manufacturing employer in Northern cities, the tariff distinguished between two kinds of sugar: “refined” and “raw.” Refined sugar that was meant for direct consumption paid a much higher rate than did raw sugar crystals intended for further refining and whitening. But by the late 1870s, new industrial sugar factories in the Caribbean began to jeopardize this protectionist structure. Technologically sophisticated, these factories could produce sugar that, while raw by the government’s standard, was consistently much closer to refined sugar than ever before (akin to sweeteners such as Sugar in the Raw today). The American industry now faced potential competition from abroad.
The country’s largest refiners mobilized on several fronts. They lobbied the United States Congress to adopt chemical instruments that could measure the percentage of sucrose in a sugar cargo, and to deem sugar refined when its sucrose content was sufficiently high. Previously, customs officers had judged the purpose of a sugar cargo by its color, smell, taste and texture, as people throughout the sugar trade had done for centuries. Now refiners argued that such sensory methods were ripe for abuse because they depended on a subjective appraisal. They demanded a scientific standard instead — one that would reveal some “raw” sugar to be nearly pure and thus subject to higher tariffs — and they prevailed.
Their plea for scientific objectivity may have sounded sensible, but it masked nefarious aims. Like the tobacco industry in the 1960s, these refiners knew that scientific questions were hard for outsiders to adjudicate, and thus easier to manipulate to an industry’s advantage. If refiners were to bribe a customs chemist to shade his results in their favor — as they were routinely accused of doing for decades, beginning in the 1870s — such corruption would be much harder for the government to detect than it had been when everyone could see and smell the same sugar.
In addition to their lobbying, refiners waged a public campaign to dissuade Americans from eating raw sugar. One of their common advertisements featured a disgusting insect that supposedly inhabited raw sugar and caused an ailment called “grocer’s itch” in those who handled it. Other pamphlets suggested that Cuban factories operated by slaves or Chinese indentured workers would “give the people sugar teeming with animals and Cuban dirt.”
The refiners’ real agenda, of course, was not Americans’ health; it was to maximize their profits from selling sugar. Thanks in part to their influence over both tariff policy and the new methods of customs collection, the big refiners were soon able to form the Sugar Trust, one of the most notorious and successful monopolies of the Gilded Age. By the early 20th century, belief in the health benefits of refined sugar was so widespread that increasing Americans’ consumption of it actually became a goal of federal policy.
Looking back at the industry’s transformation of sugar (an edible substance derived from a plant) into sucrose (a molecule), we also see the roots of “nutritionism” in United States policy. That’s the idea that what matters to human health is not food per se but rather a handful of isolable biochemical factors. As food critics like Michael Pollan and Marion Nestle have argued, nutritionism is better at helping processed-food companies market their products as healthy (“with Omega-3 added!”) than it is at promoting our well-being.
Today, the sugar industry remains politically powerful, with consequences for both public health and the environment. The Miami Herald reported this summer, for example, that the industry contributed $57 million to Florida elections in the last 22 years; meanwhile, state officials have resisted efforts to make sugar companies pay for their damage to the Everglades.
If we want to check the power of Big Sugar, we’d be well served to acknowledge the long record — past as well as present — of the industry’s machinations.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...
Continue Reading
What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...
Continue Reading
You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...
Continue Reading
Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...
Continue Reading
Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Top 5 Most Recently Viewed Articles
Significant Milestone for Cardiovalve's Heart Valve Programs The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch Recently, Cardiovalve, a prominent player in transcatheter valve replacement technology, successfully completed patient enrollment for the groundbreaking Cardiovalve TARGET study focused on...
Continue Reading
Inflammatix Expands Leadership Team Inflammatix, a leader in molecular diagnostics, has made significant strides by adding three industry veterans to its executive leadership team. This strategic expansion is aimed at spearheading the commercialization of the company's flagship product, the TriVerity™ Test. The newly appointed executives include Dr. Sam Ajizian as Chief...
Continue Reading
The Dynamics of Bitcoin and Treasury Companies In recent months, the activity surrounding Bitcoin has captured the financial world's attention, especially with treasury companies increasingly acquiring substantial amounts of BTC. However, despite this significant uptick in investment, the anticipated price escalation has not occurred as expected. Trends in Corporate...
Continue Reading
Back in 2024, Donald Trump threw down the gauntlet on Google (NASDAQ: GOOGL) during a Truth Social update, claiming he'd go after them legally if he won the presidency. This wasn’t just some offhand comment; it was a calculated move that tied into his broader campaign strategy as he sought to rally his base around claims of media bias. Media Bias or Political Theater?...
Continue Reading
Asana's Earnings Preview Asana (NYSE: ASAN) is set to release its quarterly earnings report soon, generating anticipation among investors. Understanding the key insights prior to the announcement can be vital for making informed investment decisions. Analysts have estimated that the company could report an earnings per share (EPS) of $-0.03. The Market's Expectations...
Continue Reading